Annual / Quarterly Financial Statement • Feb 8, 2024
Annual / Quarterly Financial Statement
Open in ViewerOpens in native device viewer
Basic earnings per share were 0.43 (0.16) while diluted earnings per share were SEK 0.42 (0.16).
Revenue grew 33% to SEK 1,613 million (1,216). The currency adjusted growth was 27%.
Åsa Hedin, Chair of the Board of Directors of Tobii Dynavox, informed the Nomination Committee on December 11 that she will not stand for re-election at the 2024 Annual General Meeting. The Nomination Committee has therefore initiated the recruitment process to find her successor.
| SEK m (except for earnings per share) | Q4 2023 |
Q4 2022 |
Δ | Δ Organic | Full year 2023 |
Full year 2022 |
Δ Δ Organic | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 473 | 362 | 31% | 24% | 1,613 | 1,216 | 33% | 20% |
| Gross margin | 69% | 65% | - | - | 68% | 65% | - | - |
| EBITDA | 104 | 61 | 72% | - | 317 | 206 | 54% | - |
| Operating profit/loss (EBIT) | 56 | 25 | 128% | 91% | 155 | 82 | 88% | 45% |
| EBIT margin | 11.9% | 6.8% | - | - | 9.6% | 6.8% | - | - |
| Net profit/loss for the period | 45 | 17 | 163% | - | 104 | 49 | 114% | - |
| Earnings per share, (SEK) | 0.43 | 0.16 | 163% | - | 0.99 | 0.46 | 114% | - |
| Earnings per share after dilution (SEK) | 0.42 | 0.16 | 160% | - | 0.98 | 0.46 | 112% | - |
| Cash flow after continuous investments | 63 | 41 | - | - | 145 | -26 | - | - |
Our strong performance throughout 2023 continues, characterized by a substantial growth in sales and a more than doubled operating profit in the closing quarter of the year. As previously, growth was solid across all geographical areas and user groups. To realize our long-term growth potential, we are committed to investing in new staff, skills and tools to boost the scalability of the business. The low level of awareness regarding communication aids among prescribers and potential users presents an enormous opportunity for us to make a meaningful difference, while also significantly growing our business.
Sales growth continued to be robust in the last quarter of the year. Denominated in local currency, it was just over 30 percent for the quarter and 27 percent for the full year. In the US, the upward adjustment of reimbursement rates by Medicare for our products, 9 percent for 2023, was fully reflected in the fourth quarter. In 2024, the equivalent increase will be 2.6 percent. We continue to see substantial growth across all customer types and product categories. Sales to user groups that benefit from symbol-based communication, typically children or younger users with autism diagnoses, are however growing faster than other user groups. The past several quarters clearly demonstrate that the benefits of scale in our business translates topline growth into increased operating margin. We expect this trend to continue as sales grows even further.
Acquisitions is an integral part of our growth journey, and we place significant emphasis on business logic and synergies when assessing potential candidates. The integration of our longstanding German supplier partner Rehadapt, a transaction finalized in early September, is progressing well. The company seamlessly complements our offering with its mounting solutions for communication aids, while also strengthening our position in Germany.
Our growth is driven by a number of factors. The synergy of our robust product offering and committed employees, coupled with a market in its early phases with minimal penetration, points to significant long-term potential. In practice, awareness about the communication aids that we and our industry peers can offer never reaches the majority of people in need of assistive technology. This situation remains true even in the most developed countries. The root cause is the lack of knowledge about communication aids among the key groups responsible for prescribing them: speech-language pathologists and occupational therapists. In many cases, relevant training related to the available assistive technology is either non-existent or severely limited. Our commitment to large scale training initiatives are an important contribution to this. .
Against the backdrop of two million new cases diagnosed worldwide annually, we have supplied around 25,000 more communication aids in 2023 compared with the previous year. While it is indeed gratifying that we can assist more individuals, the increase represents only a fraction of the estimated number of new cases where individuals require assistive communication aids. For example, in the US, our largest market by far, the proportion of speech-language pathologists who have prescribed a communication aid at least once per year is barely 5 percent of the professional community.
I am convinced that our historically robust growth in 2023 is a direct outcome of our long-term efforts to educate and share knowledge about the products and solutions we can offer, combined with their meaningful impact on the lives of users and their families. When coupled with our strong market position, this indicates that our long-term business potential is considerable even though building competence and awareness can be categorized as more of a marathon than a sprint. With a substantial dose of humility, particularly directed at our fantastic organization, we bring the record year of 2023 to a close, while maintaining a strong sense of confidence in the future.
Join us on February 21 for a Capital Markets Day in Stockholm, where we will offer a more indepth presentation of our business and future strategy.
Fredrik Ruben, CEO

Fredrik Ruben CEO, Tobii Dynavox
Group revenue increased 31% to SEK 473 million (362). The currency adjusted growth was 30%, organic sales grew by 24%. As in the previous quarters of 2023, growth was robust across all markets, as well as in all product and user groups. Currency movements had a positive impact of 0.5% on revenue and acquisitions contributed 6%.
Consolidated gross profit amounted to SEK 324 million (233), corresponding to a gross margin of 69% (65). The net increase was mainly attributable to progressively higher sales prices. In the fourth quarter of last year, the gross margin was negatively affected by non-recurring costs of about SEK 5 million relating to high component prices.
Operating profit totaled SEK 56 million (25) and the operating margin was 11.9% (6.8).
Operating expenses increased organically about 18%. The increase in operating expenses was affected by factors such as significant investments in staff in the sales and marketing organization and new agreements on salaries and benefits that entered into force on April 1. The cost of the long-term incentive programs was affected by the increase in the Tobii Dynavox share price during the quarter and increased by approximately SEK 3 million. Investments in systems and tools to manage a growing business also contributed to the cost increase.
Costs for research and development after capitalizations and amortizations increased by 1 MSEK compared with the corresponding quarter last year.
Financial items amounted to SEK -8 million (-10) and mainly consisted of interest on external loans. Profit before tax was SEK 49 million (15).
Tax for the quarter amounted to SEK -4 (2) million, of which SEK -7 (-3) million related to deferred tax.
Profit for the period was SEK 45 million (17). Basic earnings per share were 0.43 (0.16) while diluted earnings per share were SEK 0.42 (0.16).
Higher exchange rates, primarily USD/SEK, had a positive impact on revenue of SEK 2 million and on operating profit of SEK 2 million compared with the corresponding quarter last year.
Cash flow from operating activities before changes in working capital amounted to SEK 88 million (52). Change in working capital amounted to SEK 14 million (18).
Cash flow from investing activities amounted to SEK -48 million (-28), of which SEK -24 million (-20) was capitalization of R&D costs. During the quarter, an amortization of the credit facility of SEK 15 million was made. The recently acquired subsidiary Rehadapt also repaid all of its external loans, totaling SEK 6 million. Cash flow for the period was SEK 29 million (0).
At the end of the quarter, the Group had cash and cash equivalents of SEK 161 million (107). Consolidated net debt totaled SEK 612 million (522), including SEK 98 million (59) in IFRS 16 finance leases.
The second installment regarding the acquisition of Rehadapt, corresponding to 5% of the payment, has been made during the quarter.
REVENUE, SEK M, AND GROSS MARGIN, %

| SEK m | Q4 2023 |
Q4 2022 |
Full year 2023 |
Full year 2022 |
|---|---|---|---|---|
| Revenue 8 |
473 | 362 | 1,613 | 1,216 |
| Revenue change: | 31% | 48% | 33% | 40% |
| - of which organic | 24% | 18% | 20% | 16% |
| - of which currency | 1% | 20% | 6% | 18% |
| - of which acquisitions | 6% | 9% | 7% | 6% |
| Gross margin | 69% | 65% | 68% | 65% |
| Operating profit/loss (EBIT) | 56 | 25 | 155 | 82 |
| EBIT change | 128 % | 85 % | 88 % | 37 % |
| EBIT margin | 11.9 % | 6.8 % | 9.6 % | 6.8 % |
| SEK m | Q4 2023 |
Q4 2022 |
Full year 2023 |
Full year 2022 |
|---|---|---|---|---|
| Europe | 89 | 71 | 289 | 207 |
| North America | 363 | 275 | 1253 | 942 |
| Other countries | 21 | 16 | 71 | 67 |
| Total revenue | 473 | 362 | 1,613 | 1,216 |
| SEK m | Q4 2023 |
Q4 2022 |
Full year 2023 |
Full year 2022 |
|---|---|---|---|---|
| Total R&D expenditures | -42 | -41 | -149 | -136 |
| Capitalization | 24 | 20 | 83 | 79 |
| Amortization | -27 | -24 | -98 | -81 |
| R&D expenses in the income statement | -45 | -44 | -163 | -138 |
Group revenue increased 33% to SEK 1,613 million (1,216). The currency adjusted growth was 27%, organic sales grew by 20% There was good growth globally, as well as in all product and user groups. Currency movements had a positive impact of 6% on revenue and acquisitions contributed with 7%.
Consolidated gross profit amounted to SEK 1,094 million (788), corresponding to a gross margin of 68% (65). The increase was mainly attributable to the normalization of component and freight costs, some economies of scale, and progressively higher sales prices.
Operating profit totaled SEK 155 million (82) and the operating margin was 9.6% (6.8).
Operating expenses were affected by non-recurring costs of approximately SEK 7 million, mainly related to the acquisition of Rehadapt Engineering. Including these costs, operating expenses increased organically by around 17 percent. The increase in operating expenses was affected by factors such as significant staff increases in the sales and marketing organization and new agreements on salaries and benefits that entered into force on April 1. Investments in systems and tools to manage a growing business also contributed to the cost increase. In the comparative period, costs were lower than normal due to the effects of the pandemic on the level of activity relating to travel, events, conferences, etc.
Costs for research and development after capitalizations and amortizations increased by 25 MSEK compared with the corresponding period last year, mainly related to normalization of development costs as well as even higher depreciation costs because of new product launches. Investments relate to the development of proprietary products, the majority of which involve software and voice technology.
Financial items amounted to SEK -36 million (-29) and mainly consisted of interest on external loans. Profit before tax was SEK 119 million (54).
Tax for the year amounted to SEK -15 (-5) million, of which SEK -2 (-0.5) million related to deferred tax. Profit for the period was SEK 104 million (49). Basic earnings per share were 0.99 (0.46) while diluted earnings per share were SEK 0.98 (0.46).
Higher exchange rates, primarily USD/SEK, had a positive impact on revenue of SEK 68 million and on operating profit of SEK 13 million compared with the corresponding period last year.
Cash flow from operating activities before changes in working capital amounted to SEK 268 million (179). Change in working capital amounted to SEK 9 million (-83).
Cash flow from investing activities amounted to SEK -297 million (-197), of which SEK -83 million (-79) was capitalization of R&D costs. Cash flow for the period was SEK +59 million (-99).
At the end of the period, the Group had cash and cash equivalents of SEK 161 million (107). Consolidated net debt totaled SEK 612 million (522), including SEK 98 million (59) in IFRS 16 finance leases. Net debt in relation to the last twelve months EBITDA was 1.9
To finance the acquisition of Rehadapt Engineering, Tobii Dynavox has increased its total credit facility with Swedbank to SEK 800 million by signing and extending its credit facility with an additional term loan of SEK 100 million. Tobii Dynavox has used this new term loan and its revolving credit facility to pay for the acquisition of Rehadapt.
The total utilized part of the credit facility and term loan was SEK 678 million at the end of the period.
The number of employees converted to full-time equivalents at the period end was 701 (562). Acquired companies contributed with an increase of 57 FTEs.
On September 7, 2023, Tobii Dynavox completed the acquisition of all shares in the German company Rehadapt Engineering. After entering the agreement on 30 June 2023, the purchase price has been adjusted to EUR 16.6 million on a cash and debt free basis. Additionally, a potential earn-out consideration of up to EUR 3.5 million will be paid 12 months after closing of the transaction, depending on the continued financial development of Rehadapt. Rehadapt is consolidated into the Group as of September 1.
Rehadapt is a provider of medically certified mounting solutions for assistive technology, including out-of-the-box and flexible solutions to support individual communication, independent mobility kits and customized accessories. Based on over 20 years of expertise and innovative development, Rehadapt has created a well-respected brand and a valuable asset base in the field of mounting solutions. Rehadapt's products are currently sold together with Tobii Dynavox's products as well as by many other companies in assistive communication. Rehadapt has approximately 55 employees and is headquartered in Kassel, Germany with a local subsidiary and distribution center in the United States. Rehadapt's turnover in 2022 was approximately EUR 10 million with an adjusted EBIT margin of approximately 20%. The seller, Rehadapt's CEO Uli Ehlert, will remain with Rehadapt for a period of at least one year.
The board of Directors proposes to the Annual General Meeting that no dividends shall be paid for fiscal year 2023.
| SEK m | Note | Q4 2023 |
Q4 2022 |
Full year 2023 |
Full year 2022 |
|---|---|---|---|---|---|
| Revenues | 8 | 473 | 362 | 1,613 | 1,216 |
| Cost of goods and services sold | -149 | -128 | -519 | -428 | |
| Gross profit | 324 | 233 | 1,094 | 788 | |
| Selling expenses | -162 | -132 | -585 | -451 | |
| Research- and development expenses | -45 | -44 | -163 | -138 | |
| Administrative expenses | -60 | -37 | -196 | -130 | |
| Other operating gains and losses | 0 | 4 | 5 | 13 | |
| Operating profit/loss (EBIT) | 56 | 25 | 155 | 82 | |
| Net financial items | -8 | -10 | -36 | -29 | |
| Profit/loss before tax (EBT) | 49 | 15 | 119 | 54 | |
| Tax | -4 | 2 | -15 | -5 | |
| Net profit for the period | 45 | 17 | 104 | 49 | |
| Other comprehensive income | |||||
| Items that may be reclassified to net profit for the period: |
|||||
| Translation differences | -22 | -4 | -22 | 19 | |
| Other comprehensive income for the period, net after tax |
-22 | -4 | -22 | 19 | |
| Total comprehensive income for the period | 24 | 13 | 82 | 67 | |
| Earnings per share, SEK | 0.43 | 0.16 | 0.99 | 0.46 | |
| Earnings per share, diluted, SEK | 0.42 | 0.16 | 0.98 | 0.46 | |
| Net profit/loss for the period attributable to: | |||||
| Parent Company's shareholders | 45 | 17 | 104 | 49 | |
| Net profit/loss for the period | 45 | 17 | 104 | 49 | |
| Total comprehensive income for the period attributable to: |
|||||
| Parent Company's shareholders | 24 | 13 | 82 | 67 | |
| Total comprehensive income for the period | 24 | 13 | 82 | 67 |
| SEK m | Dec 31 2023 |
Dec 31 2022 |
|---|---|---|
| ASSETS | ||
| Non-current assets | ||
| Intangible fixed assets | 847 | 674 |
| Property, plant and equipment | 51 | 37 |
| Right-of-use assets | 91 | 50 |
| Dererred tax asset | 55 | 59 |
| Financial and other non-current assets | 13 | 15 |
| Total non-current assets | 1,056 | 835 |
| Current assets | ||
| Trade receivables | 270 | 237 |
| Inventories | 130 | 88 |
| Other current receivables | 74 | 56 |
| Cash and cash equivalents | 161 | 107 |
| Total current assets | 635 | 488 |
| TOTAL ASSETS | 1,691 | 1,323 |
| EQUITY AND LIABILITIES | ||
| Equity | 298 | 211 |
| Total equity | 298 | 211 |
| Non-current liabilities | ||
| Borrowings, non-current | 616 | 521 |
| Lease liabilities | 73 | 40 |
| Deferred tax libilities | 22 | 9 |
| Other non-current liabilities | 142 | 117 |
| Total non-current liabilities | 853 | 687 |
| Current liabilities | ||
| Borrowings, current | 59 | 49 |
| Lease liabilities | 25 | 18 |
| Other current liabilities | 456 | 358 |
| Total current liabilities | 540 | 425 |
| Total liabilities | 1,393 | 1,112 |
| TOTAL EQUITY AND LIABILITIES | 1,691 | 1,323 |
| Attributable to Parent Company shareholders | ||||||||
|---|---|---|---|---|---|---|---|---|
| SEK m | Share capital |
Reserves | Retained earnings |
Total equity |
||||
| Opening balance, Jan 1, 2022 | 1 | 1 | 138 | 139 | ||||
| Comprehensive income for the period | 19 | 49 | 67 | |||||
| Share based payments | 5 | 5 | ||||||
| Acquisition of own shares | -1 | -1 | ||||||
| Closing balance, Dec 31, 2022 | 1 | 19 | 191 | 211 | ||||
| Opening balance, Jan 1, 2023 | 1 | 19 | 191 | 211 | ||||
| Comprehensive income for the period | -22 | 104 | 82 | |||||
| Share based payments | 9 | 9 | ||||||
| Acquisition of own shares | -4 | -4 | ||||||
| Closing balance, Dec 31, 2023 | 1 | -2 | 300 | 298 |
| SEK m | Q4 2023 |
Q4 2022 |
Full year 2023 |
Full year 2022 |
|---|---|---|---|---|
| Cash flow from operating activities | ||||
| Profit before tax (EBT) | 49 | 15 | 119 | 54 |
| Depreciations and amortization | 48 | 36 | 162 | 124 |
| Other non cash items | -2 | 2 | -0 | 8 |
| Taxes paid | -7 | -1 | -13 | -6 |
| Cash flow before changes in working capital | 88 | 52 | 268 | 179 |
| Change in working capital | 14 | 18 | 9 | -83 |
| Cash flow from operating activities | 102 | 69 | 277 | 96 |
| Investing activities | ||||
| Investments in intangible assets | -25 | -21 | -89 | -87 |
| Investments in tangible assets | -14 | -5 | -46 | -32 |
| Other | 0 | -3 | 2 | -4 |
| Continuous investments | -39 | -28 | -133 | -122 |
| Cash flow after continuous investments | 63 | 41 | 145 | -26 |
| Aquisitions | -9 | 0 | -164 | -75 |
| Cash flow from investing activities | -48 | -28 | -297 | -197 |
| Financing activities | ||||
| Proceeds from borrowings | -21 | -30 | 99 | 26 |
| Repayment of lease liability | -6 | -4 | -20 | -16 |
| Other financing activities | 1 | -6 | -0 | -7 |
| Cash flow from financing activities | -26 | -41 | 79 | 2 |
| Cash flow for the period | 29 | 0 | 59 | -99 |
| Cash and cash equivalents at the beginning of the period |
140 | 109 | 107 | 197 |
| Currency translation impact on cash and cash equivalents |
-8 | -2 | -5 | 8 |
| Cash and cash equivalents at the end of the period |
161 | 107 | 161 | 107 |
The principal activity of the Group's Parent Company, Tobii Dynavox AB (publ), is research, development, and sales of computer software and computer-related hardware that helps individuals with various disabilities to live richer and more independent lives. The number of employees in the Parent Company is approximately 126.
Net sales for the Parent Company, Tobii Dynavox AB, for the period October 1 to December 31 2023 amounted to SEK 209 million (142) of which SEK 157 million (86) refers to sales to group companies and SEK 53 million (56) to external customers. Operating profit for the corresponding period was SEK 19 million (-10). Investments in property, plant and equipment and intangible assets totaled SEK -27 million (-20) for the quarter. At the end of the period, the Parent Company had SEK 32 million (23) in cash and cash equivalents.
| SEK m | Q4 2023 |
Q4 2022 |
Full year 2023 |
Full year 2022 |
|---|---|---|---|---|
| Revenues | 209 | 142 | 751 | 582 |
| Cost of goods and services sold | -90 | -75 | -341 | -289 |
| Gross profit | 119 | 68 | 410 | 293 |
| Selling expenses | -27 | -34 | -95 | -84 |
| Research- and development expenses | -40 | -37 | -144 | -123 |
| Administrative expenses | -55 | -47 | -180 | -161 |
| Other operating gains and losses | 22 | 41 | 56 | 48 |
| Operating profit/loss (EBIT) | 19 | -10 | 46 | -26 |
| Financial items | -7 | -9 | -34 | -9 |
| Profit/loss before tax (EBT) | 12 | -18 | 12 | -36 |
| Tax | -3 | 7 | -3 | 7 |
| Net profit/loss for the period | 9 | -11 | 9 | -29 |
| SEK m | Dec 31 2023 |
Dec 31 2022 |
|---|---|---|
| NON-CURRENT ASSETS | ||
| Intangible assets | 327 | 397 |
| Property, plant and equipment | 10 | 7 |
| Financial assets | 499 | 281 |
| Total non-current assets | 836 | 685 |
| CURRENT ASSETS | ||
| Inventories | 38 | 28 |
| Trade receivables | 21 | 18 |
| Receivables from Group companies | 114 | 82 |
| Other current assets | 23 | 10 |
| Cash and cash equivalents | 32 | 23 |
| Total current assets | 227 | 161 |
| TOTAL ASSETS | 1,063 | 846 |
| EQUITY AND LIABILITIES | ||
| Equity | 138 | 124 |
| Untaxed reserves | 1 | 1 |
| NON-CURRENT LIABILITIES | ||
| Borrowings, non-current | 616 | 521 |
| Liabilities to Group companies, non- current | 63 | 47 |
| Other non-current liabilities | 20 | 16 |
| Total non-current liabilities | 699 | 584 |
| CURRENT LIABILITIES | ||
| Borrowings, current | 59 | 49 |
| Trade payables | 55 | 40 |
| Liabilities to Group companies, current | 3 | 4 |
| Other current liabilities | 108 | 44 |
| Total current liabilites | 226 | 138 |
| Total liabilites | 925 | 722 |
| TOTAL EQUITY AND LIABILITES | 1,063 | 846 |
| Q4 2023 |
Q4 2022 |
Full year 2023 |
Full year 2022 |
|
|---|---|---|---|---|
| Earnings per share, SEK | 0.43 | 0.16 | 0.99 | 0.46 |
| Earnings per share, diluted, SEK | 0.42 | 0.16 | 0.98 | 0.46 |
| Equity per share, SEK | 2.8 | 2.0 | 2.8 | 2.0 |
| EBITDA, SEKm | 104 | 61 | 317 | 206 |
| Operating profit (EBIT), SEKm | 56 | 25 | 155 | 82 |
| EBITA, MSEK | 88 | 50 | 262 | 166 |
| Cash flow from operating activities, SEKm | 102 | 69 | 277 | 96 |
| Cash flow after continuous investments, SEKm | 63 | 41 | 145 | -26 |
| Working capital, SEKm | -108 | -85 | -108 | -85 |
| Total assets, SEKm | 1,691 | 1,323 | 1,691 | 1,323 |
| Net debt, SEKm | 612 | 522 | 612 | 522 |
| Net Debt/EBITDA LTM | - | - | 1.9 | 2.5 |
| Equity, SEKm | 298 | 211 | 298 | 211 |
| Equity/assets ratio, % | 18 | 16 | 18 | 16 |
| Debt/equity, factor | 2.6 | 3.0 | 2.6 | 3.0 |
| Gross margin, % | 69 | 65 | 68 | 65 |
| EBITDA margin, % | 22 | 17 | 20 | 17 |
| Operating margin, % | 11.9 | 6.8 | 9.6 | 6.8 |
| Average number of outstanding shares, million | 104.9 | 104.9 | 104.9 | 104.9 |
| Average number of outstanding shares after dilution, million |
106.6 | 105.4 | 106.3 | 105.3 |
| Number of outstanding shares at period end, million | 104.9 | 104.9 | 104.9 | 104.9 |
| Number of outstanding shares after dilution at period end, million |
106.6 | 105.4 | 106.6 | 105.4 |
| Average number of employees | 696 | 569 | 629 | 525 |
Definitions, see note 11.
| 2023 | 2022 | 2021 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Q4 | Q3 | Q2 | Q1 | Q4 | Q3 | Q2 | Q1 | Q4 | Q3 | Q2 | Q1 | |
| Revenue, SEKm | 473 | 424 | 381 | 335 | 362 | 320 | 288 | 246 | 245 | 255 | 165 | 207 |
| Gross Margin, % | 69 | 68 | 68 | 66 | 65 | 67 | 64 | 64 | 64 | 67 | 64 | 67 |
| EBITDA, SEKm | 104 | 92 | 65 | 56 | 61 | 59 | 44 | 43 | 38 | 66 | 1 | 50 |
| EBIT, SEKm | 56 | 48 | 29 | 21 | 25 | 25 | 16 | 17 | 13 | 42 | -23 | 28 |
| Operating Margin, % | 11.9 11.4 | 7.6 | 6.3 | 6.8 | 7.8 | 5.4 | 7.0 | 5.4 | 16.5 | (14.1) 13.5 | ||
| Profit/Loss before tax, SEKm | 49 | 41 | 17 | 12 | 15 | 18 | 9 | 11 | 9 | 37 | -29 | 23 |
| Profit/Loss for the period, SEKm |
45 | 35 | 17 | 7 | 17 | 16 | 6 | 10 | 5 | 21 | -13 | 16 |
Tobii Dynavox applies International Financial Reporting Standards (IFRS) as adopted by the European Union. This interim report has been prepared in accordance with IAS 34, Interim Financial Reporting.
Tobii Dynavox's interim report contains condensed financial statements. For the Group, this mainly means that the note disclosures are limited compared with the financial statements presented in the annual report. The financial statements of the Parent Company are generally presented in condensed format, with limited disclosures compared with the annual accounts. The interim reports for Tobii Dynavox AB have been prepared in accordance with the Swedish Annual Accounts Act and standard RFR 2, Accounting for legal entities.
The accounting policies applied are in effect in all periods and are consistent with the accounting policies applied in Tobii Dynavox Annual and sustainability report 2022.
The amount of allocated stock units as per December 31, 2023, is 1 532 749. The dilutive effect is expected to be a maximum of 1.6 percent.
The number of stock units allocated under the 2020 plan amounts to 199 061 share rights as of December 31, 2023. The number of stock units allocated under the 2021 plan amounts to 242 191 share rights as of December 31, 2023.
The 2022 plan has resulted in an allocation as of December 31 of 413 497 stock units.
The 2023 Annual General Meeting resolved to adopt a new long-term incentive program, LTI 2023. The number of stock units allocated under the 2023 program amounts to 678,000 as of December 31, 2023.
The number of stock units that are not yet allocated is 367 503.
In addition to the above allocated stock units, approximately 270,000 additional common shares may be issued to cover the company's social security costs.
Tobii Dynavox business risks include the economic climate, the competitive situation, currency risks, credit risks in relation to customers, financing risks, the risk of impairment write-downs of capitalized R&D and other intangible assets, and regulatory risks (Tobii Dynavox in the U.S. is under the supervisory control of the U.S. Food and Drug Administration (FDA)). More information on risks and risk management can be found in the Tobii Dynavox Annual and Sustainability Report for 2022.
The assessment of which operating segments exist in the Group shall be based on the internal reporting provided to the chief operating decision maker. The chief operating decision maker is the function responsible for allocation of resources and analyzing the segment's profit/loss. In the Tobii Dynavox Group, this function has been identified as Group Management.
The financial information provided to Group Management within Tobii Dynavox, as a basis for decisions on the allocation of resources, applies to the business as a whole without any subdivision into underlying segments. Given this situation, the management of the Tobii Dynavox Group has determined that the busi-ness as a whole should be considered a segment until further notice. Sales by geographic market is broken down into the following markets: North America, Europe and other countries.
Significant related party transactions are disclosed in the Group's Note 28 in the Tobii Dynavox Annual and Sustainability Report for 2022. There have been no material changes in related party relationships or transactions compared with those described in the 2022 Annual and Sustainability Report.
More information on the Group's sustainability efforts can be found in the Tobii Dynavox Annual and Sustainability Report 2022.
Tobii Dynavox has a chattel mortgage of SEK 50 million to Swedbank. The Group has no contingent liabilities.
As of December 31, 2023, Tobii Dynavox held 104,851,201 common shares, each carrying one vote.
| SEK m | Q4 2023 |
Q4 2022 |
Full year 2023 |
Full year 2022 |
|---|---|---|---|---|
| REVENUE BY PRODUCT TYPE | ||||
| Goods | 442 | 331 | 1,493 | 1,103 |
| Services | 30 | 30 | 113 | 107 |
| Royalty | 2 | 2 | 7 | 6 |
| Total revenues | 473 | 362 | 1,613 | 1,216 |
| REVENUE BY DATE OF REVENUE RECOGNITION | ||||
| Point in time | 409 | 303 | 1,359 | 1,022 |
| Over time | 63 | 59 | 254 | 194 |
| Total revenues | 473 | 362 | 1,613 | 1,216 |
On September 7, 2023, Tobii Dynavox completed the acquisition of all shares in the German company Rehadapt Engineering. After entering the agreement on 30 June 2023, the purchase price has been adjusted to EUR 16.6 million on a cash and debt free basis. The payment for the acquisition has been made in two instalments. Additionally, a potential earn-out consideration of up to EUR 3.5 million will be paid 12 months after closing of the transaction depending on the continued financial development of Rehadapt.
Rehadapt is a provider of medically certified mounting solutions for assistive technology, including out-of-the-box and flexible solutions to support individual communication, independent mobility kits and customized accessories. Based on over 20 years of expertise and innovative development, Rehadapt has created a well-respected brand and a valuable asset base in the field of mounting solutions. Rehadapt's products are currently sold together with Tobii Dynavox's products as well as by many other companies in assistive communication. Rehadapt has approximately 55 employees and is headquartered in Kassel, Germany with a local subsidiary and distribution center in the United States. Rehadapt's turnover in 2022 was approximately EUR 10 million with an adjusted EBIT margin of approximately 20%. The seller, Rehadapt's CEO Uli Ehlert, will remain with Rehadapt for a period of at least one year.
Rehadapt was included in the Group's accounts from September 1, 2023.
As a result of this acquisition, Tobii Dynavox expects to both strengthen its product offering and come closer to users in the countries where the acquisition is active, with the hope of giving more people a voice. Tobii Dynavox also expects to reduce costs through synergies.
The following table summarize the purchase consideration paid and the preliminary fair value of assets acquired, and liabilities assumed for the acquisition of Rehadapt Engineering.
| Rehadapt¹ | |
|---|---|
| SEK m | |
| Breakdown of Purchase considerations | |
| Cash consideration | 174 |
| Contingent consideration | 42 |
| Consideration short term receivable | -1 |
| Total consideration | 214 |
| Change in acquired assets and liabilities | |
| Technology | 19 |
| Brands | - |
| Customer relations/contracts | 33 |
| Other fixed assets | 21 |
| Net other assets and liabilities | -40 |
| Cash and cash equivalents | 10 |
| Deferred tax liability | 16 |
| Net identidiable assets and libilities | 60 |
| Goodwill | 154 |
| Impact on cash and cash equivalents | |
| Cash consideration (included in cash flow from investing activities) |
-174 |
| Cash and cash equivalents of acquired companies (included in cash flow from investing activities) |
10 |
| Acquisition costs (included in cash flow from operating activities) |
-7 |
| Total impact on cash and cash equivalents | -171 |
| Impact on sales and operating profit (loss) during the holding period |
|
| Sales | 32 |
| Operating profit (loss) | 7 |
| Impact on sales and operating profit (loss) as if the acquisitions had taken plance on 1 January 2023 |
|
| Sales | 85 |
|---|---|
| Operating profit (loss) | 24 |
¹ The acquisition analysis is preliminary
| Note 10. Financial instrument |
||||||
|---|---|---|---|---|---|---|
| Dec 31 2023 | Dec 31 2022 | |||||
| SEK m | Carrying amount |
Fair value | Carrying amount |
Fair value | ||
| Financial liabilities measured at fair value | ||||||
| Contingent considerations |
39 | 39 | 0.1 | 0.1 |
The Group categorizes financial assets and financial liabilities measured at fair value into a fair value hierarchy based on the information used to value each asset or liability. For financial instruments in level 3, information that is material to the fair value of the asset or liability is not observable and the Group's own assessments are applied.
Liabilities relating to contingent consideration 2023 relate in their entirety to the acquisition of Rehadapt Engineering while contingent considerations for 2022 related to Obear Technologies Limited and is classified under level 3.
The company presents certain financial measures in the interim report that are not defined under IFRS (so-called alternative performance measures according to ESMA guidelines). Management believes that this information helps investors to analyze the Group's performance and financial position. Investors should consider these disclosures as a complement rather than a substitute for financial reporting under IFRS.
The tables below show how the alternative performance measures that are not directly reconcilable to the financial statements are calculated.
| SEK m | Q4 2023 |
Q4 2022 |
Full year 2023 |
Full year 2022 |
|---|---|---|---|---|
| Gross margin | ||||
| Gross profit | 324 | 233 | 1,094 | 788 |
| Revenues | 473 | 362 | 1,613 | 1,216 |
| Gross margin, % | 69% | 65% | 68% | 65% |
| SEK m | Q4 2023 |
Q4 2022 |
Full year 2023 |
Full year 2022 |
|---|---|---|---|---|
| EBITDA and EBITDA-margin | ||||
| Operating profit | 56 | 25 | 155 | 82 |
| Amortization and impairment on intangible assets |
32 | 25 | 107 | 84 |
| Depreciation, amortization and impairment on tangible assets |
17 | 11 | 55 | 40 |
| EBITDA | 104 | 61 | 317 | 206 |
| Revenue | 473 | 362 | 1,613 | 1,216 |
| EBITDA-marginal, (%) | 22% | 17% | 20% | 17% |
| SEK m | Q4 2023 |
Q4 2022 |
Full year 2023 |
Full year 2022 |
|---|---|---|---|---|
| EBITA | ||||
| Operating profit | 56 | 25 | 155 | 82 |
| Amortization R&D | 27 | 23 | 98 | 80 |
| Amortization purchased immaterial assets | 4 | 2 | 10 | 4 |
| EBITA-margin | 88 | 50 | 262 | 166 |
| Revenue | 473 | 362 | 1,613 | 1,216 |
| EBITA-margin, % | 19% | 14% | 16% | 14% |
| SEK m | Q4 2023 |
Q4 2022 |
Full year 2023 |
Full year 2022 |
| Equity/share | ||||
| Equity | 298 | 211 | 298 | 211 |
| Average number of outstanding shares, million |
105 | 105 | 105 | 105 |
| Equity/share | 2.8 | 2.0 | 2.8 | 2.0 |
| SEK m | Q4 2023 |
Q4 2022 |
Full year 2023 |
Full year 2022 |
| Net debt | ||||
| Cash and cash equivalents | 161 | 107 | 161 | 107 |
| Interest-bearing liabilities | 773 | 628 | 773 | 628 |
| Net debt | 612 | 522 | 612 | 522 |
| SEK m | Q4 2023 |
Q4 2022 |
Full year 2023 |
Full year 2022 |
| Net debt/EBITDA ratio | ||||
| Net debt | - | - | 612 | 522 |
| EBITDA last twelve months | - | - | 317 | 206 |
| Net debt/EBITDA LTM | - | - | 1.9 | 2.5 |
| SEK m | Q4 2023 |
Q4 2022 |
Full year 2023 |
Full year 2022 |
| Organic growth | ||||
| Revenue current year | 473 | 362 | 1,613 | 1,216 |
| Currency effect | -2 | -50 | -68 | -156 |
| Acquisition effect | -23 | -22 | -83 | -49 |
| Currency-adjusted income corresponding period last year excluding acquisitions |
448 | 290 | 1,462 | 1,011 |
| Revenue corresponding period previous year |
362 | 245 | 1,216 | 872 |
| Organic growth | 86 | 45 | 246 | 140 |
| Organic growth, % | 24% | 18% | 20% | 16% |
| SEK m | Q4 2023 |
Q4 2022 |
Full year 2023 |
Full year 2022 |
|---|---|---|---|---|
| Working capital | ||||
| Inventories | 130 | 88 | 130 | 88 |
| Trade receivables | 270 | 237 | 270 | 237 |
| Other receivables | 74 | 56 | 74 | 56 |
| Trade payables | -100 | -78 | -100 | -78 |
| Other liabilities | -482 | -388 | -482 | -388 |
| Working capital | -108 | -85 | -108 | -85 |
| SEK m | Q4 2023 |
Q4 2022 |
Full year 2023 |
Full year 2022 |
| Operating margin (EBIT-margin) | ||||
| Operating profit | 56 | 25 | 155 | 82 |
| Revenue | 473 | 362 | 1,613 | 1,216 |
| Operating margin, % | 11.9% | 6.8% | 9.6% | 6.8% |
| SEK m | Q4 2023 |
Q4 2022 |
Full year 2023 |
Full year 2022 |
| Net debt/equity ratio | ||||
| Interest-bearing liabilities | 773 | 628 | 773 | 628 |
| Equity | 298 | 211 | 298 | 211 |
| Net debt/equity ratio, factor | 2.6 | 3.0 | 2.6 | 3.0 |
| SEK m | Q4 2023 |
Q4 2022 |
Full year 2023 |
Full year 2022 |
| Equity/assets ratio | ||||
| Equity | 298 | 211 | 298 | 211 |
| Total assets | 1,691 | 1,323 | 1,691 | 1,323 |
| Equity/assets ratio, % | 18% | 16% | 18% | 16% |
| Key Performance measures | Definition | Justification for use of metrics |
|---|---|---|
| Number of employees | Average number of full-time employees during the period, including part-time em ployees converted to FTEs |
Number of employees is a measure of the number of employees in the Company needed to generate profit for the period. |
| Gross margin, % | Gross profit relative to the operations' net sales |
Gross margin is used to measure produc tion profitability. |
| EBITA | Operating profit/loss before amortization and impairment of intangible assets |
EBITA is used to measure earnings from operating activities excluding amortization and impairment of intangible assets. |
| EBITDA | Operating profit/loss before depreciation, amortization and impairment |
EBITDA is used to measure earnings from operating activities excluding depreciation, amortization and impairment. |
| EBITDA margin, % | Operating profit/loss before deprecia tion/amortization in relation to net sales |
The EBITDA margin is used to illustrate EBITDA in relation to sales. |
| Equity per share | Equity divided by average number of shares outstanding |
A measure of the proportion of the compa ny's recognized equity that each share rep resents. |
| Cash flow after current invest ments |
Cash flow from operating and investing activities |
Cash flow after current investments is used as a measure of the cash flow generated by operating activities and investments. |
| Net debt | Interest-bearing liabilities less cash and cash equivalents |
Net debt represents the Company's capac ity to pay off all debts should they fall due for payment as of the balance sheet date using the Company's available cash and cash equivalents on the balance sheet date. |
| Net debt/EBITDA | Net debt at the end of the period in relation to rolling 12-month EBITDA |
A measure of financial risk showing net debt to cash generation. |
| Organic growth, % | Change in total revenue for the period ad justed for acquisitions, disposals and cur rency, compared with total revenue for the comparative period |
Organic growth is used to analyze the un derlying change in sales driven by compa rable units between different periods. |
| Working capital | Inventories, trade receivables and other Inventories, accounts receivable and other current receivables less accounts payable and other liabilities |
Working capital is used to measure the Company's ability to meet short-term capi tal requirements. |
| Operating margin (EBIT margin), % |
Operating profit/loss in relation to net sales |
The operating margin is used to illustrate EBIT in relation to sales and is a measure of the Company's profitability. |
| Net debt/equity, factor | Interest-bearing liabilities divided by share holders' equity |
Net debt-equity ratio measures the extent to which the Company is financed by loans. |
| Equity/assets ratio, % | Shareholders' equity as a percentage of to tal assets |
The equity/assets ratio shows the percent age of total assets financed by the share holders through equity. |
Stockholm, February 8, 2024
Åsa Hedin Chairman of the Board Charlotta Falvin Board Member
Carl Bandhold Board Member
Henrik Eskilsson Board Member
Maarten Barmentlo Board Member
Caroline Ingre Board Member
Fredrik Ruben CEO
The report has not been subject to review by the Company's auditors.
This is a translation of the original Swedish interim report. In the event of a discrepancy between this translation and the Swedish original, the Swedish interim report takes precedence.
This information is inside information that Tobii Dynavox AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out below, on February 8, 2024, at 07:30 CET.
A web presentation will be held in English today at 09.00 (CET). See investors.tobiidynavox.com for more information about the conference. The images from the presentation can then be downloaded from the website.
Fredrik Ruben, Chief Executive Officer, Tel. +46 (0) 8-522 950 20 Linda Tybring, Investor Relations, CFO, [email protected]
Tobii Dynavox AB (publ) • Corporate ID number: 556914-7563 Mailing address: Löjtnantsgatan 25, 115 50 Stockholm, Sweden Tel. +46 (0) 8-522 950 20 www.tobiidynavox.com
| Capital markets day | February 21, 2024 |
|---|---|
| Annual Report 2023 | Week 14/15 2024 |
| Interim Report Q1 2024 | April 23, 2024 |
| Annual general meeting | May 3, 2024 |
| Interim Report Q2 2024 | July 18, 2024 |
| Interim Report Q3 2024 | October 23, 2024 |
| Interim Report Q4 2024 | February 5, 2025 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.